Clinical Trial Update: Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update indicates withdrawal in new onset and established patients with type 1 diabetes; study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Tolerion, Inc. | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: ACTIVE_NOT_RECRUITING